{
    "Ingredient": "ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE",
    "DF;Route": "TABLET;ORAL",
    "Trade_Name": "OSENI",
    "Applicant": "TAKEDA PHARMS USA",
    "Strength": "EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
    "Appl_Type": "N",
    "Appl_No": 22426,
    "Product_No": 6,
    "TE_Code": null,
    "Approval_Date": "Jan 25, 2013",
    "RLD": "Yes",
    "RS": "No",
    "Type": "DISCN",
    "Applicant_Full_Name": "TAKEDA PHARMACEUTICALS USA INC"
}